Patent US4241086A successfully refreshed from Google Patents.
US4241086A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for treating rheumatism
Assignee: Santen Pharmaceutical Co Ltd
•
Filing: 1979-10-05
•
Granted: 1980-12-23
•
Expires: 1999-10-05
Abstract
Abstract A method for treating rheumatism and/or arthritis in mammals afflicted therewith by administering an effective amount of N-(2-mercapto-2-methylpropanoyl)-L-cysteine or a pharmacologically acceptable salt thereof.
Inventors
- 👤 Jun-ichi Iwao
- 👤 Tadashi Iso
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 12:33
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195; A61P; A61P29/00
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
35 words
A method for treating rheumatism and arthritis in a mammal afflicted with at least one of the said conditions comprising administering to said mammal an effective dose of N-(2-mercapto-2-methylpropanoyl)-L-cysteine or a pharmacologically acceptable salt thereof.
Claim 2
Independent Claim
35 words
A method for treating rheumatism and arthritis in a mammal afflicted with at least one of the said conditions comprising administering to said mammal an effective dose of N-(2-mercapto-2-methylpropanoyl)-L-cysteine or a pharmacologically acceptable salt thereof.
Claim 3
Dependent Claim
18 words
The method of claim 1 wherein the dose is between 0.2 and 20 mg per kg a day.
References Cited (Backward Citations)
US4053651A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-12-23 | 1984-06-23 | 1984-12-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-12-23 | 1988-06-23 | 1988-12-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-12-23 | 1992-06-23 | 1992-12-23 | $7700.00 | Window Closed / Lapsed |